[Letter: Paroxysmal supraventricular and ventricular tachycardia].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001073:Aprindine / Q000627:therapeutic use; D006352:Heart Ventricles; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000517:prevention & control*; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001073:Aprindine; D010672:Phenytoin; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine
Paroxysmale supraventrikuläre und ventrikulre Tachykardie